Entera Bio Ltd expected to post a loss of 7 cents a share - Earnings Preview

Entera Bio

08/05/2023 13:21

* Entera Bio Ltd  ENTX.OQ   ENTX.O  is expected to show a
rise in
quarterly revenue when it reports  results 
    * The Jerusalem Israel-based   company is expected to report
 a
127.3% increase in revenue to $100 thousand from $44 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Entera Bio Ltd is
for a
loss of 7 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 14.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$5​, above​ its last closing price of $0.82. ​​​

This summary was machine generated May 8 at 12:21 GMT.  All
figures in US dollars  unless otherwise stated